“I think vitiligo is one of these conditions that’s been ignored for so long and right now my passion and excitement is that we are able to talk to our patients and give them hope,” says Dr. Desai.

Don’t miss the rest of our series on vitiligo, in which Dr. Desai’s shares vitiligo management pearls from his presentation at the AAD Virtual Meeting Experience (VMX):

Talk to your vitiligo patients about their treatment goals

How to classify disease activity in vitiligo patients

The role of antioxidants in vitiligo treatment

Vitiligo subtypes indicate unstable, active disease


Desai S. What's New in Vitiligo. Therapeutic Hotline. AAD VMX 2020; June 12, 2020.

Videos

American Academy of Dermatology 

Vitiligo can be psychologically devastating for patients. Expert Seemal R. Desai, M.D., FAAD, shares how recent advances in vitiligo treatment offer hope to patients impacted by the disease.

Advances in vitiligo give patients hope

In the video below, Dr. Desai explains vitiligo subtypes, including confetti vitiligo and trichrome vitiligo, a topic he covered during his presentation at the AAD Virtual Meeting Experience (VMX) in June.

best practices for treating unstable vitiligo

 Vitiligo can be psychologically devastating for patients. Dr. Desai shares how recent advances in vitiligo treatment offer hope to patients impacted by the disease.

Subtypes such as confetti vitiligo and trichrome vitiligo can be signs of unstable active disease, says expert Seemal R. Desai, M.D., FAAD.

“I think that JAK inhibitors are really exciting right now in our quest to find an effective, long-term, safe treatment - as well as potentially a cure for vitiligo,” says Dr. Desai. Find out how he uses these medications in the video below.

 Up next, Dr. Desai explains confetti vitiligo and trichrome vitiligo.

Expert Seemal R. Desai, M.D., FAAD, highlights new therapeutics that may impact the future of vitiligo management, a topic he discussed at the AAD Virtual Meeting Experience (VMX) in June. 

What’s new in vitiligo treatment?

View the video below to discover how Dr. Desai uses antioxidants to treat vitiligo, a topic he discussed at the AAD Virtual Meeting Experience (VMX) in June.

 What’s new in vitiligo treatment? Dr. Desai offers his insight in our upcoming video.

Antioxidants can be a valuable part of your vitiligo therapeutic armamentarium, says expert Seemal R. Desai, M.D., FAAD. 

View the video below to learn best practices for treating patients with unstable disease.

 Antioxidants can be a valuable part of your vitiligo therapeutic armamentarium. Dr. Desai shares why in our upcoming video.

Expert Seemal R. Desai, M.D., FAAD, offers practical tips for stabilizing patients who present with active, spreading vitiligo, a topic he discussed at the AAD Virtual Meeting Experience (VMX) in June.

Best practices for unstable vitiligo

In this video, Dr. Desai explores these three broad categories of disease activity and what they entail.

What are your patient's goals? Dr. Desai discusses the importance of 

defining treatment goals when meeting with vitiligo patients

More from Dr. Desai’s AAD VMX presentation:

 In our upcoming video, Dr. Desai covers best practices to employ when treating unstable vitiligo.

Is your patient’s vitiligo stable, unstable or recalcitrant? Expert Seemal R. Desai, M.D., FAAD, discusses how he classifies disease activity in his practice.

“I think that discussing what the patient ultimately wants to achieve on their vitiligo journey is the most important part of that first consultation,” he says. View the video below to hear how Dr. Desai approaches these conversations.

 In our next video, Dr. Desai highlights how to classify disease activity in vitiligo patients.

Expert Seemal R. Desai, M.D., FAAD, stresses the importance of defining treatment goals when meeting with vitiligo patients, a topic he covered during his presentation at the AAD Virtual Meeting Experience (VMX) in June.



In this video, Dr. Ko shares what she’s learned from recent case reports investigating the multitude of skin symptoms occurring in COVID-19 patients.

More topics from Dr. Ko’s presentation at the 

Skin findings in patients with suspected COVID-19

This skin lesion may signal severe disease in COVID-19 patients

Please note, this video was recorded July 3 and information regarding COVID-19 may have changed as more research has become available.


Ko C. COVID-19 histopathologic findings. What's New In Dermatopathology. AAD VMX 2020; June 12, 2020.

Expert Christine Ko, M.D., FAAD, discusses case reports exploring the variability of skin manifestation in patients with or suspected of COVID-19 infection.

Dermatopathologist dissects COVID-19 case reports  

“A patient who truly has bruise-like lesion that are branching should – if they are not already in the hospital – be in touch with their doctor right away and be evaluated,” says Dr. Ko. Learn why in the video below.

common skin findings in patients with suspected COVID-19 infection

, which she discussed during her presentation at the 

Dr. Ko covers case reports exploring the variability of skin manifestation in patients with or suspected of COVID-19 infection.

Most skin manifestations associated with COVID-19 resolve as the disease progresses, says expert Christine Ko, M.D., FAAD. But there is one type of lesion that providers and patients will not want to ignore, she warns.

 in June, Dr. Ko discussed common skin findings in individuals with suspected COVID-19 infection. Learn about the corresponding histopathological finding associated with these skin manifestation in the video below.

 In our next video, Dr. Ko highlights which skin symptom should be a red flag to providers.

Please note, this video was recorded July 3 and information regarding skin manifestations associated with COVID-19 may have changed.

Learn about the histopathology of skin findings associated with potential COVID-19 infection from expert Christine Ko, M.D., FAAD.

Latest Conference Articles